| 2024-06-12 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,000 0.008% | $50.62 | $506,190 | +1.82% | |
| 2024-06-11 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,000 0.0079% | $50.01 | $500,110 | +0.7% | |
| 2022-12-06 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,000 0.0073% | $56.12 | $561,180 | -30.57% | |
| 2022-12-05 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,000 0.0073% | $55.74 | $557,370 | -30.02% | |
| 2022-12-02 | Sale | Halozyme Therapeutics, Inc. HALO | director | 10,000 0.0072% | $58.80 | $588,000 | -34.15% | |
| 2021-12-01 | Nautilus Biotechnology, Inc. NAUT | director | 30,000 0.0357% | $4.47 | $134,105 | -22.47% | ||
| 2021-11-30 | Nautilus Biotechnology, Inc. NAUT | director | 20,000 0.0223% | $4.57 | $91,400 | -28.35% | ||
| 2021-02-17 | Talis Biomedical Corporation TLIS | director | 62,500 0.315% | $16.00 | $1M | -65.14% | ||
| 2013-05-30 | Sale | Illumina, Inc. ILMN | Sr VP & General Manager | 2,836 0.0023% | $70.80 | $200,789 | +37.33% | |
| 2013-04-11 | Sale | Illumina, Inc. ILMN | Sr VP & General Manager | 11,550 0.0093% | $57.95 | $669,323 | +41.9% |